Symbols

BEAT

HeartBeam·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Signals Analysis

Bullish signal 1

Bearish signal 0

EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About BEAT

Heartbeam, Inc.

A cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection

Industry

Healthcare Equipment and Supplies

Established Date

06/11/2015

Listing Date

11/11/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

heartbeam.com

Security Type

Common stock

Office address

2118 Walsh Avenue, Suite 210, Santa Clara, CA 95050

Business

Introduction

HeartBeam, Inc., was incorporated under the laws of the State of Delaware on June 11, 2015. The Company is a medical technology company focused on developing and commercializing higher resolution Holter solutions that enable the detection and monitoring of heart disease outside of healthcare facility settings. The company's ability to develop higher resolution ECG solutions is achieved through the development of the company's proprietary and patented VECG technology platform. The company's vector ECG technology enables the development of three-dimensional (3 D) images of cardiac electrical activity by showing the spatial position of ECG waveforms that have been shown in earlier studies to provide the same or better diagnostic capabilities as traditional hospital ECG systems.

Earnings Call

Q1/2025

Estimate EPS--

Actual EPS-0.18

Estimate Revenue--

Actual Revenue0

HeartBeam's Q1 2025: Key Contradictions in Patient Engagement, Pricing, and FDA Clearance

May 20,2025 10:13·
Earnings Decrypt

Q2/2025

Estimate EPS--

Actual EPS-0.15

Estimate Revenue--

Actual Revenue0

HeartBeam's Q2 2025: Unpacking Contradictions in FDA Clearance, Pricing Strategy, and Leadership Appointments

Aug 13,2025 09:44·
Earnings Decrypt

Company Financials

EPS

BEAT has released its 2025 Q3 earnings. EPS was reported at -0.15, versus the expected -0.16, beating expectations. The chart below visualizes how BEAT has performed over recent quarters, highlighting trends in earnings surprises.